CombinatoRx and Clinical Data Collaborate on Adenosine Agonist for Cancer

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 8 (Table of Contents)

Published: 28 Aug-2009

DOI: 10.3833/pdr.v2009.i8.1189     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Clinical Data and CombinatoRx sign a licensing agreement valued at up to US$252 M for the development of a novel cancer drug to treat multiple myeloma and other B-cell cancers...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details